Skip to main content
SpringerLink
Log in

Treatment of Peptic Ulcer in the Elderly

Proton Pump Inhibitors and Histamine H2 Receptor Antagonists

  • Drug Therapy
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Some problems remain unresolved in the short and long term treatment of peptic ulcer in the elderly. These mainly concern the physiology and pathophysiology of the aging stomach, the pharmacokinetic and pharmacodynamic properties of antisecretory drugs, and the presence of different risk factors from those in patients under 60 years of age.

The aim of this article is to provide a critical review of the present-day clinical and pharmacological knowledge concerning the use of antisecretory drugs [histamine H2 receptor antagonists (H2RAS) and proton pump inhibitors] in the treatment of peptic ulcer in the elderly, taking into account the pathogenetic role of Helicobacter pylori.

The available data from controlled trials show that the clinical efficacy and safety of short and long term antisecretory treatment for peptic ulcer are similar in elderly and younger patients. In addition, there are no significant differences between H2RAS and proton pump inhibitors.

In particular, in patients with nonsteroidal anti-inflammatory drug (NSAID)-induced gastric or duodenal ulcer, H2RAS and omeprazole have proved useful even when NSAID therapy is continued. However, as in younger patients, significantly lower efficacy has been documented in short and long term prevention of gastroduodenal damage, limited to duodenal lesions for H2RAS and gastric lesions for omeprazole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bozymski EM, Isaacs KL. Special diagnostic and therapeutic considerations in elderly patients with upper gastrointestinal disease. Clin Gastroenterol 1991; 13 Suppl. 2: S65–75

    Article  Google Scholar 

  2. Kurata JH, Haile BM, Elashoff JD. Sex differences in peptic ulcer disease. Gastroenterology 1985; 88: 96–100

    PubMed  CAS  Google Scholar 

  3. Collier DSJ, Pain JA. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63

    Article  PubMed  CAS  Google Scholar 

  4. Lamy PP. A consideration of NSAID use in the elderly. Geriatr Med Today 1988; 7: 1–11

    Google Scholar 

  5. Lamy PP. Physiological changes due to age: pharmacodynamic changes of drug action and implications for therapy. Drugs Aging 1991; 1: 385–404

    Article  PubMed  CAS  Google Scholar 

  6. Krentz K, Jablonowski H. Functional and histological gastric changes with age. In: Hellemans J, VanTrappen G, editors. Gastrointestinal tract disorders in the elderly. Edinburgh: Churchill Livingstone, 1984: 62–9

    Google Scholar 

  7. Pilotto A, Vianello F, DiMario F, et al. Effect of age on gastric acid, pepsin, pepsinogen group A, and gastrin secretion in peptic ulcer patients. Gerontology 1994; 40: 253–9

    Article  PubMed  CAS  Google Scholar 

  8. Farinati F, Formentini S, Delia Libera G, et al. Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age: a morphometric study. Gerontology 1993; 39: 146–51

    Article  PubMed  CAS  Google Scholar 

  9. Goldschmiedt M, Barnett CC, Schwarz BE, et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977–90

    PubMed  CAS  Google Scholar 

  10. Cryer B, Redfern JS, Lee E, et al. Decline in gastroduodenal mucosal prostaglandins with aging in humans: relationship with gastric acid secretion [abstract]. Gastroenterology 1991; 100: 427A

    Google Scholar 

  11. Pilotto A. Gastric ulcer in the elderly. Ital J Gastroenterol 1994; 26 Suppl. 1: 10–5

    PubMed  CAS  Google Scholar 

  12. Beers M, Ouslander J. Risk factors in geriatric drug prescribing: a practical guide to avoiding problems. Drugs 1989; 37: 105–12

    Article  PubMed  CAS  Google Scholar 

  13. Parkin DM, Henry CR, Quirk J, et al. Deviation from prescribed drug treatment after discharge from hospital. BMJ 1976; 2: 686–8

    Article  PubMed  CAS  Google Scholar 

  14. Stewart RB. Noncompliance in the elderly: is there a cure? Drugs Aging 1991; 1: 163–7

    Article  PubMed  CAS  Google Scholar 

  15. Chiverton SG, Hunt RH. Pharmacokinetics and pharmacodynamics of treatments for peptic ulcer disease in the elderly. Am J Gastroenterol 1988; 83: 211–5

    PubMed  CAS  Google Scholar 

  16. Okada M, Yao K, Fuchigami T, et al. Factors influencing the healing rates of gastric ulcer in hospitalized patients. Gut 1984; 25: 881–5

    Article  PubMed  CAS  Google Scholar 

  17. Wright JP, Marks IN, Mee AS, et al. Ranitidine in the treatment of gastric ulcer. Afr Med J 1982; 61: 155–8

    CAS  Google Scholar 

  18. Herman RP, Piper DW. Factors influencing the healing rate of chronic gastric ulcer. Am J Dig Dis 1973; 1: 1–6

    Article  Google Scholar 

  19. Sonnenberg A, Muller-Lissner SA, Vogel E, et al. Predictors of duodenal ulcer healing and relapse. Gastroenterology 1981; 81: 1061–7

    PubMed  CAS  Google Scholar 

  20. Bianchi Porro G, Lazzaroni M. Prescribing policy for antiulcer treatment in the elderly. Drugs Aging 1993; 3: 308–19

    Article  PubMed  CAS  Google Scholar 

  21. Mills RJ, Begun JM, Holland CE, et al. Ranitidine for duodenal ulcer disease in the elderly: a retrospective review of four multicentre trials. Geriatr Drug Ther 1988; 3: 43–6

    Google Scholar 

  22. Tarn HC, Lee YC, Wong HY, et al. Healing of gastric ulcer in the elderly: a double blind study of cetraxate versus ranitidine. Clin Gastroenterol 1989; 11: 183–6

    Article  Google Scholar 

  23. Battaglia G, Di Mario F, Vio A, et al. H2 blockers in the treatment of ulcer disease in the elderly. Adv Ther 1990; 7: 78–85

    Google Scholar 

  24. Battaglia G, Di Mario F, Vigneri S, et al. Peptic ulcer in the elderly — a double blind, short term study comparing nizatidine 300 mg with ranitidine 300 mg. Aliment Pharmacol Ther 1993; 7: 643–8

    Article  PubMed  CAS  Google Scholar 

  25. Battaglia F, Di Mario F, Dotto P, et al. Markers of slow healing peptic ulcer in the elderly: a study on 1052 ranitidine treated patients. Dig Dis Sci 1993; 8: 1414–21

    Article  Google Scholar 

  26. Ehsanullah RSB, Mills J, Wood JR. Use of ranitidine to treat duodenal ulceration in the elderly [abstract]. Gastroenterology 1991; 100: A58

    Google Scholar 

  27. Dickinson RJ, Royston CMS, Sutton DR. A comparison of famotidine and ranitidine in an elderly population: a multicentre study. Postgrad Med J 1988; 62 Suppl. 2: 63–5

    Google Scholar 

  28. Howden CW, Jones DB, Peace KE, et al. The treatment of gastric ulcer with antisecretory drugs: relationship of pharmacological effect to healing rate. Dig Dis Sci 1988; 33: 619–24

    Article  PubMed  CAS  Google Scholar 

  29. Bianchi Porro G, Lazzaroni M. Peptic ulcer disease: medical treatment. In: Gustavsson S, Kumar D, Graham DY, editors. The stomach. New York: Churchill Livingstone, 1992: 246–65

    Google Scholar 

  30. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on long term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 703–8

    Google Scholar 

  31. DiMario F, Leandro G, Battaglia G, et al. Do concomitant diseases and therapies affect the persistence of ulcer symptoms in the elderly? Dig Dis Sci 1996; 41: 17–21

    Article  CAS  Google Scholar 

  32. Cedeberg C, Anderson T, Skanberg I. Omeprazole: pharmacokinetics and metabolism in man. Scand J Gastroenterol 1989; 24 Suppl. 166: 36–42

    Google Scholar 

  33. Lind T, Cedeberg C, Olausson M, et al. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and plasma fasting gastrin. Eur J Clin Pharmacol 1991; 40: 557–60

    PubMed  CAS  Google Scholar 

  34. Walan A. Therapy with omeprazole, an acid pump inhibitor. In: Swab EA, Szabo S, editors. Ulcer disease: investigation and basis for therapy. New York: Marcel Dekker, 1991: 217–30

    Google Scholar 

  35. Pilotto A, DiMario F, Battaglia G, et al. The efficacy of two doses of omeprazole for short and long term peptic ulcer treatment in the elderly. Clin Ther 1994; 6: 935–41

    Google Scholar 

  36. Murakami M, Saita H, Takahashi Y, et al. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients. Clin Gastroenterol 1995; 20 Suppl. 2: S79–82

    Article  Google Scholar 

  37. Bianchi Porro G, Lazzaroni M. Prevention and treatment of nonsteroidal gastroduodenal lesions. Eur J Gastroenterol Hepatol 1993; 5: 420–32

    Article  Google Scholar 

  38. Lancaster Smith MJ, Jadeberg ME, Jackson DA. Ranitidine in the treatment of nonsteroidal antiinflammatory drug associated gastric and duodenal ulcer. Gut 1991; 32: 252–5

    Article  PubMed  CAS  Google Scholar 

  39. Walan A, Bader JP, Classem M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75

    Article  PubMed  CAS  Google Scholar 

  40. Bank S, Greenberg RE, Magier D, et al. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin related ulcers. Clin Ther 1991; 13: 304–18

    PubMed  CAS  Google Scholar 

  41. Bank S, Zucker S, Greenberg RE, et al. Effect of famotidine on gastric ulcer healing: a comparison between nonsteroidal and aspirin-induced ulceration and idiopathic ulcers [abstract]. Am J Gastroenterol 1991; 86: 1308

    Google Scholar 

  42. Darle N, Almskog B, Bergegardh S, et al. Treatment of acute massive gastroduodenal haemorrhage with cimetidine in elderly patients. Ann Chir Gynaecol 1984; 73: 64–8

    PubMed  CAS  Google Scholar 

  43. Steinheber FU. Ageing and the stomach. Clin Gastroenterol 1985; 14: 657–88

    PubMed  CAS  Google Scholar 

  44. Drayer DS, Romankiewicz J, Lorenzo B, et al. Age and renal clearance of cimetidine. Clin Pharmacol Ther 1982; 31: 45–50

    Article  PubMed  CAS  Google Scholar 

  45. Young CJ, Daneshmend TK, Roberts CJC. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine. Gut 1982; 23: 819–23

    Article  PubMed  CAS  Google Scholar 

  46. Greene DS, Szego PL, Anslow JA, et al. The effect of age on ranitidine pharmacokinetics. Clin Pharmacol Ther 1986; 39: 300–5

    Article  PubMed  CAS  Google Scholar 

  47. Inotsume N, Nishimura N, Fujyiama S, et al. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers. Eur J Clin Pharmacol 1989; 36: 517–20

    Article  PubMed  CAS  Google Scholar 

  48. Lin JH, Chremos AN, Yeh KC, et al. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man. Eur J Clin Pharmacol 1988; 34: 41–6

    Article  PubMed  CAS  Google Scholar 

  49. Callaghan JT, Rubin A, Knadler MP, et al. Nizatidine, an H2 receptor antagonist: disposition and safety in the elderly. Clin Pharmacol 1987; 27: 618–24

    CAS  Google Scholar 

  50. Ritschel WA. Cimetidine dosage regimen for patients with renal failure and for geriatrics patients. Eur J Clin Pharmacol 1982; 23: 501–4

    Article  PubMed  CAS  Google Scholar 

  51. Sorkin EM, Darvey DL. Review of cimetidine drug interactions. Drug Intell Clin Pharm 1983; 17: 110–20

    PubMed  CAS  Google Scholar 

  52. Mitchard M. Ranitidine drug interactions: a literature review. Pharmacol Ther 1987; 32: 293–325

    Article  PubMed  CAS  Google Scholar 

  53. Langtry HD, Grant SM, Goa KL. Famotidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989; 38: 551–90

    Article  PubMed  CAS  Google Scholar 

  54. Price AH, Brogden RN. Nizatidine: a preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in peptic ulcer disease. Drugs 1988; 36: 521–39

    Article  PubMed  CAS  Google Scholar 

  55. Murdoch D, McTavish D. Roxatidine acetate: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders. Drugs 1991; 42: 240–60

    Article  PubMed  CAS  Google Scholar 

  56. Hennan NE, Carpenter DU, Janda SM. Famotidine associated mental confusion in elderly patients. Drug Intell Clin Pharm 1988; 22: 976–8

    Google Scholar 

  57. Solvell L. The clinical safety of omeprazole. Scand J Gastroenterol 1989; 24 Suppl. 166: 106–10

    Article  Google Scholar 

  58. Pilotto A, Franceschi M, Lagni M. The effect of omeprazole on serum concentrations of theophylline, pepsinogens A and C, and gastrin in elderly duodenal ulcer patients. Am J Ther 1995; 2: 43–6

    Article  PubMed  Google Scholar 

  59. Howden CW, Reid JL. The effect of antacids and metoclopramide on omeprazole absorption and disposition. Br J Clin Pharmacol 1988; 25: 779–80

    Article  PubMed  CAS  Google Scholar 

  60. Delhotal-Landes B, Cournot A, Vermerie N, et al. The effect of food and antacids on lansoprazole absorption and distribution. Eur J Drug Metab Pharmacokinet 1991; Special Issue III: 315–20

    Google Scholar 

  61. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 333: 984–91

    Article  PubMed  CAS  Google Scholar 

  62. Bardhan KD, Hinchliffe RFC, Bose K, et al. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Aliment Pharmacol Ther 1988; 2: 395–405

    Article  PubMed  CAS  Google Scholar 

  63. Penston J, Wormsley KG. Efficacy and safety of long term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989; 24: 1145–52

    Article  PubMed  CAS  Google Scholar 

  64. Walan A, Bianchi Porro G, Hentschel E, et al. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987; 22: 397–405

    Article  PubMed  CAS  Google Scholar 

  65. Lee FI, Hardman M, Jadeberg ME. Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers. Gut 1991; 32: 151–3

    Article  PubMed  CAS  Google Scholar 

  66. Pilotto A, Di Mario F, Battaglia G, et al. Efficacy and safety of peptic ulcer long term therapy in the elderly: a double blind multicentre, one year study. In: Beregi E, Gergely LA, Rajczi K, editors. Recent advances in aging science. Bologna: Monduzzi, 1993: 1133–6

    Google Scholar 

  67. Tytgat GNJ, Dixon MF. Role of Helicobacter pylori in the pathogenesis of peptic ulcer disease: practical implications for the clinician. In: Hunt RH, editor. Proton pump inhibitors and acid related disorders. Osaka: Adis International, 1994: 79–100

    Google Scholar 

  68. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 1972: 65–9

    Google Scholar 

  69. Faisal MA, Russel RM, Smaloff IM, et al. Helicobacter pylori infection and atrophic gastritis in the elderly. Gastroenterology 1990; 99: 1543–4

    PubMed  CAS  Google Scholar 

  70. Safe AF, Warren B, Corfield A, et al. Helicobacter pylori infection in elderly people: correlation between histology and serology. Age Ageing 1993; 22: 215–20

    Article  PubMed  CAS  Google Scholar 

  71. Gilinsky NH. Peptic ulcer disease in the elderly. Scand J Gastroenterol 1988; 23 Suppl. 146: 191–200

    Article  Google Scholar 

  72. Jenike MA. Cimetidine in elderly patients: review of uses and risks. Am Geriatr Soc 1982; 30: 170–3

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastrointestinal Unit, ‘L. Sacco’ University Hospital, via G.B. Grassi 74, I-20157, Milan, Italy

    Marco Lazzaroni &  Gabriele Bianchi Porro

Authors
  1. Marco Lazzaroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriele Bianchi Porro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazzaroni, M., Porro, G.B. Treatment of Peptic Ulcer in the Elderly. Drugs & Aging 9, 251–261 (1996). https://doi.org/10.2165/00002512-199609040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199609040-00003

Keywords

Search

Navigation